Tel.: 510-420-4167, Fax: 510-420-4197
Cancer Therapy
Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid†
Article first published online: 21 DEC 2009
DOI: 10.1002/ijc.25116
Copyright © 2009 UICC
Additional Information
How to Cite
Chu, R., Zhao, X., Griffin, C., Staub, R. E., Shoemaker, M., Climent, J., Leitman, D., Cohen, I., Shtivelman, E. and Fong, S. (2010), Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid. Int. J. Cancer, 127: 1209–1219. doi: 10.1002/ijc.25116
- †
Conflict of interest: Ruth Chu, Xiaoyue Zhao, Richard E. Staub, Mark Shoemaker, Isaac Cohen, Emma Shtivelman and Sylvia Fong are employees of Bionovo Inc. that supported the work carried out in this article.
Publication History
- Issue published online: 25 JUN 2010
- Article first published online: 21 DEC 2009
- Manuscript Accepted: 26 NOV 2009
- Manuscript Received: 13 MAY 2009
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer, Cancer Letters, 2012, 320, 2, 158
- 2, , , , , , , , , , Antidiabetic Effect of Oleanolic Acid: A Promising Use of a Traditional Pharmacological Agent, Phytotherapy Research, 2011, 25, 7Direct Link:
- 3, , The biological and therapeutic relevance of mRNA translation in cancer, Nature Reviews Clinical Oncology, 2011, 8, 5, 280

1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
